|
|
Article: Cephalon Announces Marketing and Distribution Agreements For Modafinil in Mexico and Taiwan.
- Article from:
- PR Newswire
- Article date:
- May 24, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST CHESTER, Pa., May 24 /PRNewswire/ --
Cephalon, Inc. (Nasdaq: CEPH), an international biopharmaceutical company, announced today that it has granted rights to market, sell and distribute modafinil to Armstrong Laboratorios de Mexico S.A.C.V. in Mexico and Sintong Chemical Industrial Co., Ltd. in Taiwan. Cephalon markets modafinil as PROVIGIL(R) (modafinil) tablets [C-IV] in the United States and several other countries.
PROVIGIL is a unique, wake-promoting agent currently approved in several countries for the treatment of excessive daytime sleepiness associated with narcolepsy. The most common side effects associated with PROVIGIL in clinical ...